Eledon Pharmaceuticals (ELDN) Other Operating Expenses (2019 - 2025)

Eledon Pharmaceuticals' Other Operating Expenses history runs 4 years deep, the most recent figure standing at -$54.3 million for Q4 2025.

• Quarterly Other Operating Expenses rose 15.21% year-over-year to -$54.3 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was -$54.3 million (up 15.21% YoY) and the FY2025 annual result came in at $7.5 million, up 111.67% from the prior year.
• Other Operating Expenses was -$54.3 million for Q4 2025 at Eledon Pharmaceuticals, up from -$64.0 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $48.6 million in Q4 2022 and bottomed at -$64.0 million in Q4 2024.
• A 3-year average of -$23.2 million and a median of -$54.3 million in 2025 frame the typical range for Other Operating Expenses.
• Peak annual rise in Other Operating Expenses reached 15.21% in 2025, while the deepest fall reached 15.21% in 2025.
• Eledon Pharmaceuticals' Other Operating Expenses stood at $48.6 million in 2022, then slumped by 231.63% to -$64.0 million in 2024, then grew by 15.21% to -$54.3 million in 2025.
• Business Quant data shows ELDN's Other Operating Expenses at -$54.3 million in Q4 2025, -$64.0 million in Q4 2024, and $48.6 million in Q4 2022.